Company
Metabolon
Metabolon is the industry’s leading metabolomics service provider, with over 25 years of experience delivering high-quality data and actionable insights to researchers worldwide.
Also known as Metabolon Inc.
- Status
- Operatingas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Customers
- researchers worldwide
- Legal name
- Metabolon Inc.
- metabolon.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Our platform combines ultra-high-performance liquid chromatography/tandem accurate mass spectrometry (UHPLC/MS/MS) with the world’s largest proprietary biochemical reference library. With over 5,400 metabolites spanning 70+ metabolic pathways, we deliver reliable data that drives biomarker discovery and supports multiomics research outcomes not possible with other methods alone.
Funding snapshot
- Total raised
- $124MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $7.5M2024-12-31
Funding rounds
- Round, 2024
- $7.5M2024-12-31, SEC form D sold, 11 investors
- Round, 2022
- $10M2022-11-01, SEC form D sold, 11 investors
- Round, 2020
- $21.8M2020-08-28, SEC form D sold, 11 investors
- Round, 2019
- $7.8M2019-08-13, SEC form D sold, 11 investors
- Round, 2018
- $7.3M2018-08-15, SEC form D sold, 9 investors
- Round, 2016
- $30M2016-08-10, SEC form D sold, 2 investors
- Round, 2015
- $5M2015-03-02, SEC form D sold, 4 investors
- Round, 2013
- $15M2013-12-16, SEC form D sold, 15 investors
- Round, 2011
- $13.2M2011-08-25, SEC form D sold, 12 investors
- Round, 2008
- $6.3M2008-04-30, SEC form D sold, 7 investors
Products
- Web
- Integrated Bioinformatics Platform
- Hardware
- Metabolon Verus Metabolomics Profiling Kit
Loading relationship preview